← FDA DRUG APPROVALS

FDA ANDA · ANDA085294

CHLORDIAZEPOXIDE HYDROCHLORIDE

Sponsor: WEST WARD

APPLICATION
ANDA085294
TYPE
ANDA
ORIGINAL APPROVAL
1977-04-06
LATEST ACTION
1990-11-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CHLORDIAZEPOXIDE HYDROCHLORIDEDiscontinued
CHLORDIAZEPOXIDE HYDROCHLORIDE 25MG · CAPSULE · ORAL

Approval history

1990-11-21Manufacturing (CMC) · Supplement 24AP
1988-05-06Labeling · Supplement 18AP
1988-05-06Manufacturing (CMC) · Supplement 22AP
1984-10-01Manufacturing (CMC) · Supplement 15AP
1984-10-01Manufacturing (CMC) · Supplement 14AP
1977-04-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →